No Data
No Data
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)
Insider Spends US$213k Buying More Shares In AN2 Therapeutics
Insider Purchase: Director at $ANTX (ANTX) Buys 5,000 Shares
Kevin Krause Named President and CEO of ArrePath
JMP Securities Maintains AN2 Therapeutics(ANTX.US) With Buy Rating, Maintains Target Price $5
TD Cowen Initiates AN2 Therapeutics(ANTX.US) With Hold Rating